2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Can nutritional interventions modulate the activation of the NLRP3 inflammasome in chronic kidney disease?

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Inflammatory and innate immune responses triggered by pathogen-associated and other danger-associated signals emerging during infections, results in the activation of cytosolic inflammasomes. The nod-like receptor pyrin domain containing 3 (NLRP3) is one of the inflammasomes mediating such responses through the activation of caspase-1, which increases the production and release of pro-inflammatory cytokines, such as IL-1β and IL-18 and induces programmed cell death through pyroptosis. NLRP3 is thought to play a crucial role in the underlying inflammatory responses in many lifestyles related chronic diseases. Consequently, research on the NLRP3 inflammasome has expanded dramatically in recent years. Although several studies have investigated the role of NLRP3 activation in chronic kidney disease (CKD), few studies have evaluated strategies to modulate its activation by means of interventions using non-pharmacological strategies. This review discusses some nutritional strategies (bioactive compounds, probiotics and caloric restriction) that have been shown to influence NLRP3 in experimental models of renal disease, and in CKD. It discusses how nutritional interventions could potentially dampen NLRP3 associated inflammatory burden, as part of nutritional strategies to prevent and treat CKD and its complications.

          Related collections

          Author and article information

          Journal
          Food Res Int
          Food research international (Ottawa, Ont.)
          Elsevier BV
          1873-7145
          0963-9969
          October 2020
          : 136
          Affiliations
          [1 ] Graduate Program in Medical Sciences, Fluminense Federal University (UFF), Niterói, Brazil. Electronic address: liviaalvarenga92@gmail.com.
          [2 ] Graduate Program in Cardiovascular Sciences, Fluminense Federal University (UFF), Niterói, Brazil.
          [3 ] Graduate Program in Cardiovascular Sciences, Fluminense Federal University (UFF), Niterói, Brazil; Institute of Nutrition, Rio de Janeiro State University (UERJ), Rio de Janeiro-RJ, Brazil.
          [4 ] Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Technology and Intervention, Karolinska Institutet, Stockholm, Sweden.
          [5 ] Institute of Cancer Sciences, MVLS, University of Glasgow, UK.
          [6 ] Department of Nephrology, Hospital Lyon Sud, INSERM 1060, Université de Lyon, F-69495 France.
          [7 ] Graduate Program in Medical Sciences, Fluminense Federal University (UFF), Niterói, Brazil; Graduate Program in Cardiovascular Sciences, Fluminense Federal University (UFF), Niterói, Brazil.
          Article
          S0963-9969(20)30331-8
          10.1016/j.foodres.2020.109306
          32846516
          8af32f89-e868-4141-ba9d-372874572e65
          Copyright © 2020 Elsevier Ltd. All rights reserved.
          History

          Bioactive compound,Chronic kidney disease,Inflammasome,Inflammation,Oxidative stress

          Comments

          Comment on this article